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KAJIAN TENTANG AKTIVITI EKSTRAK CYPERUS ESCULENTUS 
LATIVUM PADA MEKANISMA PERTUMBUHAN DAN PENGHIJRAHAN 
DALAM SEL KANSER MDA-MB-231 DAN MCF7 
 
ABSTRAK 
Cyperus esculentus L., lazimnya digunakan sebagai tepung dan minyak dalam 
industri makanan.  Kebanyakannya dimakan mentah sebagai makanan ringan kerana 
berperisa susu manis. Minyak daripada C. esculentus mengandungi beta-sitosterol, 
asid oleik dan quercetin, yang merupakan kumpulan molekul yang mempunyai sifat 
antikanser pada pelbagai sel kanser.  Kajian ini bertujuan untuk mengkaji kesan 
antiproliferatif ekstrak etanol dan air C. esculentus pada sel kanser MDA-MB-231 dan 
MCF7. Selain itu, kesan ekstrak pada kitaran sel dan aktiviti penghijrahan sel untuk 
kedua-dua sel kanser telah disiasat.  Mekanisme yang terlibat dalam aktiviti ekstrak 
tersebut juga dielusidasikan. Kaedah MTT dijalankan untuk memeriksa kesan ekstrak 
ke atas viabiliti kedua-dua sel kanser, manakala flow cytometry digunakan untuk 
menilai perkembangan kitaran sel. Selain itu, assay penyembuhan luka dan matrigel 
telah dijalankan untuk memeriksa aktiviti penghijrahan sel, manakala qPCR dan 
Western blot dilaksanakan untuk menilai ekspresi gen dan protein. Keputusan 
menunjukkan bahawa ekstrak C. esculentus hanya mengurangkan viabiliti sel kepada 
60 % pada rawatan 24 rawatan dan 80 % pada rawatan 48 jam di MDA-MB-231 dan 
MCF7, masing-masing. Tempoh rawatan yang berlanjutan dan peningkatan kepekatan 
ekstrak tidak menjejaskan viabiliti sel lagi.  Selain itu, ekstrak menghentikan kitaran 
sel di G0/G1 untuk MCF7, manakala dalam MDA-MB-231, kedua-dua tahap S dan 
G2/M penghentian kitaran sel telah diperhatikan.  Untuk kajian ekspresi mRNA, 
cyclins yang berkaitan dengan kitaran sel (CCNA2, CCNE2) dan kinase yang 
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bergantung kepada cyclin (CDK1, CDK2, CDK6) tidak dikesan dalam                      
MDA-MB-231, sedangkan hanya CCNE2 dan CDK4 tidak hadir dalam 
MCF7.  Daripada semua inhibitor kinase yang bergantung kepada cyclin yang disiasat, 
hanya gen p53 yang hadir dan ekspresinya meningkat dalam                                           
MDA-MB-231;  manakala ekspresi gen CDKN1A, CDKN2A, dan CDKN2C didapati 
meningkat dalam MCF7.  Untuk kajian protein, p44/42-MAPK dan c-Myc dikesan 
meningkat dalam MDA-MB-231.  Dalam MCF7, protein c-Jun diinduksi tetapi        
cyclin D1 dihalang.  RhoA dihalang dalam kedua-dua sel kanser yang dirawat, 
manakala Rac1/2/3 diinduksi dalam MCF7. Perencatan RhoC hanya diperhatikan 
dalam rawatan Ym di kedua-dua sel kanser.  Ekspresi CDKN1A, CDKN2A dan 
CDKN2C yang tinggi bertanggungjawab untuk penghentian fasa G0/G1 yang 
diperhatikan dalam MCF7, manakala penghentian di tahap S dan G2/M dalam       
MDA-MB-231 adalah disebabkan oleh induksi p53.  Ekspresi gen dan protein juga 
menunjukkan bahawa proliferasi MDA-MB-231 dan MCF7 serta penghentian kitaran 
sel telah dihalang melalui laluan isyarat MAPK dan c-Jun. Di samping itu, kesan 
melalui p41/p42 MAPK dan c-Jun telah dimulakan melalui modulasi cyclin D1 dan c-
Myc dalam MDA-MB-231 dan MCF7. Tambahan pula, ekstrak tersebut juga 
menurunkan motiliti MDA-MB-231 dan MCF7 melalui modulasi RhoA, RhoC dan 
Rac1/2/3. Kesan ekstrak C. esculentus didapati bergantung kepada jenis sel. Oleh itu, 
C. esculentus berpotensi untuk berfungsi sebagai sumber baru dalam membangunkan 










Cyperus esculentus L., is a tuber of family Cyperaceae which produces 
rhizomes from the base. It is used mostly as flour and oil in the food industry. In Ghana, 
it is mostly consumed raw as a snack because of its milky and sweet taste. The oil 
contains beta-sitosterol, oleic acid and quercetin, which are the compounds found to 
have anticancer property on various cancer cell lines. This research aimed to 
investigate the antiproliferative effect of the ethanolic and aqueous extracts of                
C. esculentus on MDA-MB-231 and MCF7 breast cancer cell lines. Also, the effects 
of the extracts on cell cycle progression and cell migration activity of both cell lines 
were studied. The possible mechanisms involved in the observed activity of the extract 
were also elucidated. MTT assay was run to check the extract effect on the viability of 
both cell lines, whereas flow cytometry was used to assess the cell cycle progression. 
Wound healing and Matrigel assays were run to check the cell migration activity, 
whereas qPCR and western blotting were run for gene and protein expressions, 
respectively. The results show that C. esculentus extracts only reduced the cell viability 
to 60 % at 24 hours and 80 % at 48 hours of treatment in MDA-MB-231 and MCF7, 
respectively. Prolong treatment and increase concentration did not affect the cell 
viability further. Also, the extracts induced G0/G1 cell cycle arrest in MCF7, but in 
MDA-MB-231, both S and G2/M phases cell cycle arrests were observed. For mRNA 
expression study, the cell cycle related cyclins (CCNA2, CCNE2) and cyclin-
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dependent kinases (CDK1, CDK2, CDK6) were not detected in MDA-MB-231, 
whereas only CCNE2 and CDK4 were absent in MCF7. Out of all the cyclin-
dependent kinases inhibitors investigated, only p53 gene was present and upregulated 
in MDA-MB-231; while CDKN1A, CDKN2A, and CDKN2C genes were found to be 
upregulated in MCF7. For protein study, the p44/42-MAPK and c-Myc were detected 
to be overexpressed in MDA-MB-231. In MCF7, c-Jun protein was induced but    
cyclin D1 was inhibited. RhoA was inhibited in both treated cell lines, while Rac1/2/3 
was induced only in MCF7. RhoC inhibition was observed only in the Ym-treatment 
in both cell lines. The overexpression of CDKN1A, CDKN2A and CDKN2C is 
responsible for the G0/G1 phase arrest observed in MCF7, while the S and G2/M 
phases arrest in MDA-MB-231 is due to the induction of p53. The gene and protein 
expressions also showed that MDA-MB-231 and MCF7 proliferation and its cell cycle 
arrest were inhibited via MAPK and c-Jun signaling pathways. Also, the effect through 
p44/p42 MAPK and c-Jun was initiated via the down- and up-regulation of cyclin D1 
and c-Myc in MDA-MB-231 and MCF7, respectively. In addition, the extracts 
suppress MDA-MB-231 and MCF7 motility through the modulation of RhoA, RhoC, 
and Rac1/2/3. C. esculentus extract-induced pathways are found to be cell type 
dependent. Thus, C. esculentus might serve as a potential source for the development 






Globally, breast cancer remains the most diagnosed cancer and the main cause 
of cancer-related deaths among females (Bray et al., 2018), accounting for 23 % of 
total incidence and 14 % death rate. Approximately half of the breast cancer incidences 
and 60 % of the mortality rate are estimated to befall in developing countries (Jemal 
et al., 2011).  
According to 2018 GLOBOCAN classification, female breast cancer tightly 
follows lung cancer with 11.6 % in both sexes. In contrast to other continents, the 
percentage of cancer deaths in Africa (7.3 %) and Asia (57.3 %) are higher than the 
incidence (5.8 % and 48.4 % respectively) because of the high casualty rates and the 
diverse distribution (Bray et al., 2018). A review on breast cancer care in Africa also 
showed an increase in breast cancer incidence mostly in low- and middle-income 
countries (Kantelhardt et al., 2015). The occurrence of breast cancer in Sub-Saharan 
Africa is quite low, but the survival rate is poor due to late diagnosis, lack of logistics, 
the expensive nature of the medications and treatments. Hence mortality rates are as 
high as in developed countries. Late stage in diagnosis has been found to be the main 
problem for breast cancer control. In Ghana, a study disclosed that 64.1 % of patients 
come with the late stage of the disease. The delay in diagnosis experienced in these 
countries is due to poor awareness, the high cost of available treatments, absence of 
organized early detection programs, poor facilities for accurate, timely diagnosis and 
treatment (Jedy-Agba et al., 2016).  
Among all these factors, the treatment cost is the major reason for delay 
observed mostly in low-and middle- income countries. The affected individual often 
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falls on herbal products, and traditional medicine as one of their first treatment 
alternatives to alleviate the effect and/or as a preventive measure. Thus, access to 
operational and inexpensive cancer treatments in developing-countries would 
remarkably reduce mortality, particularly in locations where health-care amenities are 
less well established. However, the increasing cost of the cancer burdens are affecting 
the economies of even the richest nations, not to talk about the developing countries. 
This also places unbearable stresses on the health-care systems. Therefore, more 
commitment is desperately needed in preventive measures and to detect early cases for 
adequate treatments. In that regards, all governments were encouraged to show 
commitment in implementing high-quality screening and early detection programs that 
are according to him an investment rather than a cost (Stewart et al., 2016). He further 
emphasis the importance of these programs in low- and middle-income countries for 
protection of the populations. Stewart summarized the importance of such calls by 
saying that the battle against cancer will not be won with treatment only, but rather 
with an effective prevention measure.  
Diet and nutrition are considered as effective strategy for the prevention of 
cancer. Epidemiological reports advised the consumption of fruits, soy products, and 
vegetables to reduce the risk of breast cancer (Li et al., 2017, Keating & Martel, 2018), 
and of some dietary natural products which might lessen the incidence and increase 
cancer survival rate (Nechuta et al., 2012; Farvid et al., 2016). Additionally, many of 
such products together with their bioactive compounds had been shown to inhibit cell 
proliferation, cause cell cycle arrest, induce metastasis, angiogenesis and apoptosis, to 
downregulate ER-α expression and finally sensitize breast tumors cells to 
chemotherapy and radiotherapy (Hu et al., 2014; Lv et al., 2014; Varinska et al., 2015;  
Gallardo & Calaf, 2016) 
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The bacterial anaerobic fermentation of plant dietary fiber in the large bowel 
produce short chain fatty acids such as butyrate which was seen to reduce cell 
proliferation and induce apoptosis in cell lines (Hague et al., 1995;  Halestrap et al., 
1997). Dietary fiber also might prevent colon cancer and interfere with the 
enterohepatic circulation of estrogens. Reduction was reported in androstenedione and 
circulating estrogen levels, and in mammary cancer growth, metastasis, and 
angiogenesis with high fiber intake (Raz et al., 2002).  
In addition, fiber-rich food is important source of Phyto-estrogens and 
estrogen-like natural compounds which might interact with and control the activity of 
ERs, thereby limitating the risk of hormone-dependent tumors such as breast cancer 
(Adlercreutz et al., 1987; Monroe et al., 2007; Vieira et al., 2012).  
Plant based polyphenols have numerous biological effects which include anti-
inflammatory, scavenging of oxidative agents, antimicrobial activity, and inhibition of 
platelet aggregation (Wachowicz, 2005; Yoon & Baek, 2005; Zhang & Tsao, 2016).  
Together with phytochemicals, some minerals and vitamins such as carotenoids, 
folate, vitamins B6, C, D and E, and selenium, might reduce cancer risk by preventing 
oxidative damage and inhibit cell proliferation. These nutrients can further induce cell-
cycle arrest, maintain DNA methylation, and/or modulate the concentrations of steroid 
hormone and hormonal metabolism (Vanaja et al., 2010; Williams et al., 2010; Beaver, 
& Dashwood, 2011; Song et al., 2015; Iqbal et al., 2017; Kapinova et al., 2018). Diallyl 
disulfide, and sulphoraphane can maintain DNA stability and enhance transcription by 
behaving as histone deacetylase inhibitors (Bianchini & Vainio, 2001; Ho et al., 2005). 
Bioactive compounds from plants such as resveratrol, curcumin, and isothiocyanates 
are known for their anti-inflammatory, antioxidant, and anti-carcinogenic activities 
(Chung et al., 2013; Hosseini & Ghorbani, 2015; Wang et al., 2015).  
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Tigernut “Cyperus esculentus lativum” is a tuber of family Cyperaceae which 
is underutilized. It produces rhizomes from the base of the tuber that is to some extent 
spherical (Figure 1.1). It grows freely and is consumed widely in Ghana, other parts 
of west Africa, parts of Europe particularly Spain and as well as in the Arabian 
Peninsula (Ejoh et al., 2006). Many thousand years ago, Tigernut was cultivated in 
region of chufa between Sudan and Egypt on the borders of the Nile River. Proof of 
Tigernut importance and value is shown archaeological searches that found earthen 
jars containing Tigernut in graves of pharaohs. Tigernut milk was classified as 
therapeutic drink due to its been highly energetic and diuretic, rich in mineral, vitamins 
C and E, and predominantly contain phosphorus and potassium (Ejoh et al., 2006).  
Tigernut tubers appear somewhat long or round with a dimension of 8 mm to 
16 mm (Figure 1.1). When hydrated, it is slightly harder more of a nut texture, but 
with a rather more intense and concentrated taste. It is cultivated twice a year in Ghana, 
but its cultivation time is between April and November. It needs continuous irrigation 
and must be properly dried before storage. The drying process is completely natural 
by sun drying and the process can take up to one month. The dehydrating process is to 
ensure longer shelf life, to prevent rot or bacterial infection. In all, it is to secure their 
quality and nutritional level. Unfortunately, the dehydration process makes the 
Tigernut skin wrinkled, a situation that limits its acceptability to some people (Belewu 
& Abodunrin, 2008). Three types of varieties of Tigernut are cultivated: black, brown 
and yellow (Umerie et al., 1997). The yellow variety is preferred over others because 
of its inherent properties such as attractive colour, large size, fleshier nature, low fat, 
and less anti-nutritional factors (Okafor et al., 2003). It also said to yield more milk 
upon extraction with protein content which is higher compared to the rest. It was 
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reported that Tigernut contain practically twice the amount of starch as potatoes tubers 
(Kuner et al., 2002). 
  









1.1. Research Rationale 
Cyperus esculentus L., a tuber which is commonly used as snack and in the food 
industry in some part of the world like Africa, Spain, and America. It contains several 
vitamins, nutrients, fiber, mono-unsaturated fatty acids, and antioxidants that make it 
suitable to be part of an anti-cancer diet. It also contains compound such as ß-sitosterol, 
quercetin, fatty hydroxamic acid, oleic acid, and nutrients like vitamin D and E which 
are proven to have anti-inflammatory, antiproliferative, anti-metastatic, immune-
stimulatory effects, and anti-cancer property. All these data increase the likelihood of 
C. esculentus to be a good candidate of an anticancer drug. Therefore, this work wants 
to determine the antiproliferative and migration activity of C. esculentus, on           
MDA-MB-231 and MCF7; and to elucidate the possible mechanisms.   
1.2. Research objectives 
The general objective of this work is to determine the antiproliferative and anti-
migration activities of C. esculentus extracts, as well as to elucidate the mechanisms 
by which these activities could be achieved. 
The specific objectives are as follows: 
i. To determine the phytochemical groups that are present and the antioxidant 
activity of the aqueous and ethanolic extracts of Tigernut.   
ii. To determine the effect of the extracts on the cell viability and the cell cycle 
progression of MDA-MB-231 and MCF7.   
iii. To evaluate the effect of the extracts on the migration and invasion of         
MDA-MB-231 and MCF7.  
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iv. To elucidate the possible cell signaling mechanisms related to cell viability, cell 
cycle, cell migration and cell invasion at both mRNA and protein expression 
levels in both cell lines. 
 
1.3. Flow chart of the research 
The flow of the work is depicted in Figure 1.2.  Two varieties of Tigernut were 
extracted in water and 70 % ethanol. The extracts were tested for phytochemicals and 
antioxidant activity. Also, MTT assay, cell cycle analysis, cell migration and invasion 
assays were performed. This is followed by the determination of genes and proteins 

























                  Figure 1. 2 Flow chart of Research
Selected Fractions: (Ym, Bm) 
Cell cycle analysis: Flow cytometry using 
Propidium Iodide (PI) dye 
Cell invasion assay:  Flow cytometry 
with Muse Anexin V cell death kit 
Lateral migration assay  
Mechanisms elucidation from genes and protein expressions using qPCR and 
Western blotting 
Qualitative analysis: 
Fehling; Salkowski; Keller-killani; 
Borntrager’s tests 
Quantitaive analysis: 
Aluminium Chloride; Folin Ciocalteau and 
DPPH assays 
Phytochemical and Antioxidant activity Cell viability test (MTT assay) 






2.1.  Introduction 
The cancer burden worldwide is expected to increase to 24 million in 2035 
from 14 million cases observed in 2012 (Stewart et al., 2016). The higher percentage 
of this increment is projected to come from developing countries where cancer 
treatment and services are hard pressed. Due to the threat and the mortality rate 
increase, no country can find its way out of the cancer menace. Therefore, it is essential 
to include preventive and earlier detection measures in the cancer control improvement 
procedures.  Around 40-50 % of cancers could have been prevented if an up-to-date 
knowledge about the risk factors was deciphered into the current public health policies 
(Stewart et al., 2016). Though progress is still needed in other areas such as weight 
control, physical activity, and mutation profiles, the progress in diet control with 
consumption of fruit, wholegrains, vegetables, and of less processed meat has helped 
in the reduction of mortality rate.  
2.2. Tigernut 
Tigernut (Cyperus esculentus) is a tuber known under numerous names such 
as: nut grass, earth or ground almond, yellow nut, and edible galingale                             
(Sánchez-Zapata et al., 2012). It has an appetizing, sweet and nutty flavour and is 
consumed either fresh, semi-dried, and/or completely dried as snack. Tigernuts are 
mostly eaten raw in Ghana as snack, but it is a vital food crop within certain 
communities in some part of West Africa. To increase their uses, researches in the 
country have focused on their nutritional values either alone and/or as a composition 
of many diets’ formulations (examples are their uses in baking, beverages and drinks 
production, cooking oil, and in cosmetic where the oil is mostly used for soap). Current 
10 
 
research and reviews on this plant have been focused mainly on the phytochemical 
compositions, organoleptic properties, biochemical activities, nutritional values, and 
mostly on the oil content and its characterizations. The medicinal values of Tigernut 
are rarely discussed, although it is widely claimed in folklore activities and is said to 
be a balance diet on its own.  
Tigernut has excellent nutritional qualities with a fat composition like olives 
(Coşkuner et al., 2002) in addition of being cholesterol and gluten free. It is also said 
to be a promising ingredient for gluten-free baked product (Aguilar et al., 2014).  
Moreover, it is a rich plant source of flavonoids (El-Habashy et al., 1989) and rich in 
water, alkaloids, fibres, saponins, digestible carbohydrates, and fatty oils (glycerides) 
(Jeong et al., 2000; Ekeanyanwu et al., 2010). Additionally, Tigernut contain elements, 
like potassium, phosphorous, calcium, zinc, iron, manganese and magnesium (Addy 
& Eteshola, 1984; Coşkuner et al., 2002; Sánchez-Zapata et al., 2012). The fatty oil 
amount in Tigernut was 25-27 % and are classified into saturated fatty acids (myristic 
acid) and unsaturated fatty acids (linoleic acid (8.37 %), oleic acid (69.25 %), stearic 
acid (5.07 %) and palmitic acid (15.19 %)) (Eteshola & Oraedu, 1996; Salem et al., 
2005; Adel et al., 2015). It is denoted that Tigernut had marked therapeutic effects for 
hyperplasia, intestinal metaplasia, and the animal experiments showed no toxic effect, 
so a safety guarantee was provided for its clinical application (Allouh et al., 2015; 
Stanley & Francis, 2018). Moreover, it is considered as analgesic, antimalarial, 
antibacterial, antimicrobial, astringent, carminative, antipyretic, diaphoretic, 
demulcent, diuretic, hypoglycemic, hypotensive, hepatoprotective, tonic, stomachic, 
vermifuge and as anti-inflammatory agent (Gupta et al., 1971; Atta & Zaman, 1989; 
Salem et al., 2005; Hanaa, 2007; Monago & Uwakwe, 2008; Nwaoguikpe, 2010; 
Gambo &, Dáu, 2014; Oyedepo et al., 2014). In vivo study of a food supplement with 
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Tigernut on mices which were induced with streptozotocin showed that Tigernuts had 
appreciable hypoglycemic and hypolipidemic effects (Hanaa, 2007). The 
comprehensive study on the lipid profiling of Tigernut oils by Adel et al. (2015) 
showed that Tigernut oils could substitute some common vegetable oils in the food 
industry. 
2.3. Cancer Risk Factors  
Cancer, in general, occurs because of individuals being exposed to 
carcinogenic agents in what they eat, drink, inhale and/or exposed to. Tobacco is 
known to be the most important risk factor for cancer which was reported to cause      
22 % deaths globally and specifically 71 % for lung cancer (Stewart et al., 2014). Also, 
specific infections by Hepatitis B and C viruses, Human papillomaviruses, and 
Helicobacter pylori are other major risk factors.  
For other major global cancers, reproductive behaviour and uses of hormonal 
drugs/products, along with differences in weight, diet, alcohol consumption and lack 
of exercise, are alleged to underlie the differences seen in the risk of breast cancer       
(Stewart et al., 2014).  Increase of 10 % in the number of processed foods in the diet 
was related to a substantial rise of more than 10 % in risks of overall and breast cancer 
(Fiolet et al., 2018; Monge & Lajous, 2018). In Ghana, the prevalence of several of 
the behavioural risk factors is high and are increasing. Some studies showed that more 
than 85 % of Ghanaians consume less than the recommended five daily servings of 
fruits and vegetables (Bosu et al., 2015). Truly, vegetable and fruit intake in Ghana is 





2.4. Phytochemicals and Cancer prevention 
Phytochemicals have shown potential in inhibiting experimental 
carcinogenesis in various type of cell lines. Most tested phytochemicals are from fruits, 
vegetables, herbs, and medicinal plants. These are phenolic compounds, terpenoids, 
flavonoids, carotenoids, and others (Thoppil & Bishayee, 2011; Iqbal et al., 2018). 
Often phytochemicals act as antioxidants especially the flavonoids, and some have 
anti-inflammatory, anti-hormone, immune-enhancing effects and anti-cancer property 
(Seeram et al., 2005; Iqbal et al., 2015; Iqbal et al., 2017). Further studies have shown 
their influence on cell cycle progress, cell differentiation, cell apoptosis, and on 
angiogenesis (Chung et al., 2013; Hosseini & Ghorbani, 2015; Wang et al., 2015). 
2.4.1. Flavonoids  
Flavonoids are a subgroup of polyphenols which can be found in fruits, coffee, 
tea, etc.  Most of these are phytonutrients such as quercetin, kaempferol, and myricetin 
which are known to have some antioxidant properties with quercetin being the highest. 
All flavonoids are suitable chelating agents and tend to be potent antioxidants. Their 
role in cancer preventions has been mostly supported by epidemiological studies and 
few animal studies.  
Dietary flavonoids are these days mostly sought after because of their cost‐
effectiveness, safety, and feasibility of oral administration. According to Kuo, the 
biological activities of dietary flavonoids depend on their structure and possible 
synergistic action with chemotherapy agents (Kuo, 1997). Further examples were also 
given on some flavonoids (Isoflavones) that have a weak affinity for the estrogen 
receptor while others do bind to such receptors (e.g. low-affinity type II estrogen 
binding sites), but the mechanism is unknown. Fisetin, a nutritional flavonoid found 
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in many vegetables and fruits is shown to prevent cancer development by affecting 
their cell cycle, inhibiting their invasion and metastasis, inducing apoptosis and 
angiogenesis; all these with no toxicity effect on the normal cells (Lall et al., 2016). It 
has been reported that cell division of MDA-MB-231 was inhibited by fisetin and 
apoptosis was conducted through mitochondrial membrane depolarization and the 
activation of CASP9, CASP8, and the cleavage of PARP 1 (Smith et al., 2016). 
Likewise, quercetin, another flavonoid compound, has also been shown to cause the 
similar cleavage and caspases responses in both MCF7 and MDA-MB-231 breast 
cancer cell lines through the expression of Bax and cyt C release (Chien et al., 2009; 
Ranganathan et al., 2015). Equally, genistein is seen to cause the inhibition of        
MDA-MB-231 cell growth via Bax and p21WAF1 molecular pathways (Li et al., 
1999; Sarkar & Li, 2003). Genistein is also involved in the G2/M cell cycle and so 
many other pathways (Pan et al., 2012). Studies have been conducted paving the way 
to up-to-date information on effects of different flavonoids against various cancer cell 
types and their mechanism(s) of action elucidated (Gupta et al., 2015; Maggioni et al., 
2015; Venturelli et al., 2016; Russo et al., 2017).  
2.4.2. Sterols 
Phytosterols or plant sterols are well known to improve blood lipid profile thus 
protecting against cardiovascular disease (Gylling et al., 2014). These days, insights 
are being gained to their role in cancer prevention and treatment. Phytosterols are 
shown to reduce cancers of breast, lung, stomach, liver, prostate, and ovary. While 
their exact mechanisms of action are not well delineated, phytosterols have been 
proposed to cause inhibitory effects through cell cycle arrest, invasion, and metastasis 
(Ramprasath & Awad, 2015). When consumed, phytosterol competes with the body’s 
cholesterol for absorption because of the similarity in structure. By blocking 
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cholesterol absorption, phytosterols reduce the blood cholesterol level. During human 
disease processes such as obesity and cancer, a lot of rewiring is done to alter 
membrane composition. A review showed the importance of phytosterol against 
cancer initiation and growth (Woyengo et al., 2009).  
Among these phytosterols are beta-sitosterol, stigmasterol, campesterol, and 
cycloartenol of which beta-sitosterol is the most abundant. β-sitosterol caused G2/M 
arrest phase and induced apoptosis via ERK-independent and phosphatidylinositol 3-
kinase/Akt pathways (Moon et al., 2008). Same apoptotic activity was observed in 
MCF7 and MDA-MB231 cell lines (Awad et al., 2007). Their effect on the plasma 
membrane and lipid metabolism in relation to their protective activity against cancer 
has also been reviewed by (Zhuang et al., 2005; Hąc-Wydro et al., 2007; Cheng et al., 
2018; Fakih et al., 2018). Lupeol and stigmasterol have also been shown to possess 
anti-cancer activity in addition to their already known anti-inflammatory activities. 
The in-vivo study has shown that these compounds inhibit cell viability, and migration, 
and cell morphogenesis via tumour necrosis factor-α (TNF-α), and VEGFR-2 
signaling pathways (Kangsamaksin et al., 2017).  
2.4.3. Steroids 
Steroids are compounds made naturally or artificially that are used as 
medications for different types of illnesses (Man et al., 2010; Yue et al., 2013; Iqbal et 
al., 2015). Steroids play an important part in the management of stress, by responding 
to reacting inflammation, infection, and a host of other functions which ranges from 
blood pressure to blood sugar controls (McEwen & Kalia, 2010; Liu et al., 2017). 
When used together with chemotherapy drugs for instance in NHL treatment, steroids 
help prevent the side effects of the treatment, to stop allergic reactions and increase 
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appetite. Most often, corticosteroids are the type of steroids used in cancer treatment. 
Corticosteroids are compounds naturally produced by the adrenal glands. It helps 
control chemotherapy-induced vomiting and nausea, treat shortness of breath in 
advanced cancer, treat superior vena cava obstruction, and reduce swelling in case of 
cancer metastasis to the brain (McEwen & Kalia, 2010). Steroids are referred to as the 
unsung heroes of cancer care because it works quietly behind the scene to minimize, 
and prevent complications, and even helping in the success of other therapies while 
radiation therapy, chemotherapy, immunotherapy, and targeted therapies get all the 
praise for killing cancer. 
2.4.4. Terpenoids  
As a major group of secondary metabolites, triterpenoids are shown to possess 
important pharmacological activities such as antioxidant, hypolipidemic, anti-
inflammatory, antibacterial, gastroprotective, immunoregulatory, antiviral and 
anticancer effect. In addition, terpenoids are said to be involved in the tumour cell 
survival, and proliferation, invasion and metastasis, and radio-resistance. Also, a 
review of the biological effects of terpenoids highlighted their chemo-preventive effect 
on breast epithelial carcinogenesis (Rabi & Bishayee, 2009).  
A diversity of terpenoids has been shown to possess pharmacological activity 
against cancer. Examples are taxanes obtained from Taxus brevifolia, vincristine and 
vinblastine from Catharanthus roseus (Cragg & Newman, 2005; Srivastava et al., 
2005). Alimentary monoterpenes likewise showed anti-tumour activity in preventing 
the development or progression of cancer, and in degenerating existed malignant 
tumours (Bardon et al., 1998). Moreover, terpenoids have been shown to exert 
cytotoxicity effect on liver cancerous cells in in-vitro and studies in-vivo, in which 
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their cellular and molecular mechanisms involved have also been elucidated (Thoppil 
& Bishayee, 2011). Certain reviews have dealt with the status and prospects of the 
relation between terpenoids and cancer prevention (Huang et al., 2012; Patlolla & Rao, 
2012). Oleanic acid, a naturally occurring pentacyclic triterpenoid with anti-
angiogenic activity (Sogno et al., 2009), re-establishes the homeostatic control of cell 
proliferation together with rosemary terpenoids and both reduce cancer risk through 
distinct mechanisms (Telang, 2018).  
2.4.5. Tannins  
Tannins are a group of astringent, and polyphenolic biomolecules that bind to 
and react with proteins and several other organic compounds such as alkaloids and 
amino acids. Due to their binding properties to proteins, pigments, basic compounds, 
metallic ions, large-molecular compounds and their display of anti-oxidant activities, 
tannins have been subject of research for their anti-cancer properties (Barrajón-Catalán 
et al., 2010; Widsten et al., 2014; Abu et al., 2016). Tannins have been found to affect 
the endoplasmic reticulum (ER) stress, to cause apoptosis in prostate cancer cells 
(Nagesh et al., 2018), HER+ breast cell line (Jordan & Booth, 2018), ER+ (Booth et al., 
2013; Ngobili et al., 2015) and fatty acid synthase over-expressed human breast cancer 
cells (Nie et al., 2016), and to induce G1/S phase arrest and inhibit different pathways 
(Darvin et al., 2015; Darvin et al., 2017).  
2.4.6. Saponins 
Mostly plant-based phytochemical, saponins can also be found from marine 
organisms. Due to their structural compositions, it has been seen to exhibit 
pharmacological effects among which are antioxidant and anticancer activities (Bang 
et al., 2005; Beit-Yannai et al., 2011; Vuong et al., 2015). Saponins were found to 
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prevent the proliferation of cancerous cells by interfering with the replication of 
cellular DNA and causing cell cycle arrest (Liu et al., 2014). It also induces CASP3 
cleavage, thus apoptosis activation (Beit-Yannai et al., 2011). Furthermore, saponins 
were shown to possess a cytotoxic effect on multidrug resistance (MDR) and non-
MDR cells (Park et al., 2010). A review by Isil et al. (2015) has highlighted the 
anticancer activity of various plants issued from their rich content of tannin and 
saponin. Similar reporting on the chemical structural and medical applications of 
saponins showed ginsenosides, and dioscin to be strong anti-tumour agents in 
inhibiting tumour angiogenesis, invasion, and metastasis, and causing cell cycle arrest 
(Shuli et al., 2010; Ong et al., 2015).  
2.5. Breast cancer  
Globally an increase in breast cancer incidence rate has been observed. For 
instance, in 2012, approximately 1.7 million cases were detected which represented   
12 % of total cancer cases and 25 % of cancer cases in women (Ferlay et al., 2015; 
Kantelhardt et al., 2015). This is a rise from 2010 when 1.6 million new cases of BC 
were detected (Forouzanfar et al., 2011), and accounted for over 500,000 deaths 
annually.  
A 2011 study from the American Cancer Society stated breast cancer as the 
most detected cancer in women, representing a change from earlier years with cervical 
cancer been the most diagnosed cancer in Sub-Sahara countries (Jemal et al., 2011). 
This analysis is consistent with cancer data reported in Cote d’Ivoire (Echimane et al., 
2000), Uganda (Gakwaya et al., 2008; Wabinga et al., 2013; Galukande et al., 2014), 
Nigeria (Akarolo-Anthony et al., 2010; Stefan et al., 2013), and Ghana (Stefan et al., 
2013; Thomas et al., 2017; Vanderpuye et al., 2017a). Though the occurrence rate 
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observed in the developing countries is low compared to the developed countries, the 
survival rate is poor resulting in a high mortality rate of about 75 % (Vanderpuye et 
al., 2017b).  Late report to the hospital with aggressive tumours, cost of treatment, lack 
of therapeutic options and lack of information are some of the causes of such high rate. 
2.5.1. Breast cancer subtypes 
Breast cancer is usually categorized into estrogen receptor positive (ER+) and 
estrogen receptor negative (ER-).  The use of biomarkers, for instance, human 
epidermal growth factor receptor 2 (HER2), and progesterone receptor (PR) further 
divided breast cancer into several molecular subtypes, for example, luminal A and B, 
HER2-positive and basal-like breast cancers (Table 2.1) (Holliday & Speirs, 2011). 
The latter is considered as triple-negative breast cancer (TNBC) in some cases because 
it lacks the expression of ER, HER2, and PR. This makes it non-responsive to most 
available treatments hence making it extremely intractable.  
Earlier studies found that Ghanaians have a threefold rise in TNBC incidence 
in comparison to African Americans, and White Americans. Explicitly, 82 % of 
Ghanaians were detected with TNBC against 26 % African Americans and 16 % White 
Americans (Stark et al., 2010; Seshie et al., 2015). Likewise, 49.4 % of tumours tested 
at Korle-Bu teaching hospital were found to be hormone-receptor-negative, with triple 
negative being the subtype most detected (Ohene-Yeboah & Adjei, 2012; Seshie et al., 
2015). The same consistency is reported from a study in Kumasi metropolis between 
July 2004 and June 2009 where 42.5 % triple negative tumour was spotted from 54 
breast cancer cases (Stark et al., 2010; Ohene-Yeboah & Adjei, 2012). 
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Table 2.1 Molecular classification of breast cancer (Holliday & Speirs, 2011) 
Subtype  Immuno-
profile 
Characteristics Example cell 
lines  
Luminal A  ER+, PR+/-, 
HER2- 
-Low expression of proliferation 
marker Ki67  
-Responsive to hormone therapy  
-Often responsive to chemotherapy 
MCF7, T47D, 
SUM185 
Luminal B ER+, PR+/-, 
HER2+ 
-High expression of proliferation 
marker Ki67 
-Usually responsive to hormone 
therapy 
-Variably responsive to 
chemotherapy 
-Variably responsive to HER2 
antibody therapies  
 (i.e. trastuzumab) 
BT474, ZR-75 
Basal  ER-, PR-, 
HER2- 
-High expression of proliferation 
marker Ki67 
-Expression of EGFR+ 
-Variable expression of a basal cell 
marker  
   cytokeratin 5/6 
-Not responsive to hormone therapy, 








-Ki67, E-cadherin, claudin-3, 
claudin-4 and claudin-7 low.  










-High expression of proliferation 
marker Ki67 
-Often responsive to HER2 antibody 




EGFR, epidermal growth factor receptor; ER, estrogen receptor; HER2, human 





2.4.1(a) MDA-MB-231 cell line 
  MDA-MB-231 are cancerous breast cell lines that are being used as models 
for numerous experimental studies (Jiang et al., 2016). Since these cells have a variety 
of mutated genes (e.g. p53, BRCA, CDKN2A, BRAF, and RAS), and express EGFR 
and TGFα, MDA-MB-231 are commonly used for testing the effects of possible anti-
cancer agents on the affected pathways (Huovinen et al., 2011; Jiang et al., 2016). It is 
an epithelial cell line derived from a pleural effusion of a Caucasian female with 
metastatic mammary adenocarcinoma.  MDA-MB-231 is TNBC making it highly 
aggressive and invasive. Classified first under the basal breast cell line, it is now 
referred to as claudin-low molecular subtype breast cancer line because of the 
downregulation of claudin-4 and claudin-3 proteins and the low expression of Ki-67.  
2.4.1(b) MCF7 cell line 
  MCF7 is a cancerous breast cell line that is not as aggressive as MDA-MB-
231. It was isolated from a 69-year old Caucasian woman in 1970. The cells do retain 
quite a few features of differentiated mammary epithelium and can process estradiol 
through cytoplasmic ERs. Their growth is said to be inhibited by TNFα. MCF7 cells 
are estrogen receptor positive breast-origin cells. Omega-3 and omega-6 fatty acids 
such as docosahexaenoic acid (DHA), arachidonic acid (AA), and eicosapentaenoic 
acid (EPA) have shown to inhibit MCF7 cell growth, and proliferation (Mansara et al., 
2015). MCF7 cells have a mutation in PIK3CA and CDKN2A genes which make them 
be a tool in research concerning the signaling pathways in which these factors are 





2.5.2. Breast cancer, risk factors, and diet 
The onset and development of breast cancer could be affected by many 
exogenous and endogenous factors. Exogenous factors comprise reproductive, 
lifestyle and environmental factors such as smoking, excessive intake of red meat and 
alcohol, overweight, lack of exercise, etc. Genetic risk factors, for example, mutations 
on breast cancer susceptibility gene 1 and 2 (BRCA1 and BRCA2), account for only 
about 5–10 % of all breast cancer occurrences.  
A long period of exposure to estrogens is also associated with a bigger risk of 
breast tumour. Though the mechanisms are not well grasped, the accepted theory 
proposed that estradiol (E2) acts through ERα in inducing cell proliferation and 
initiating mutations from replicative mistakes taken place in pre-mitotic DNA 
synthesis. These cause an increase of mutated cells which, over a period accumulate 
to encourage neoplastic transformation. The second theory is based on the genotoxic 
effect of estrogen metabolite, a non-receptor mediated mechanism. According to a 
review by Yue et al. (2013), both mechanisms are supported by the weight of evidence 
available. In addition, it was said that estrogen metabolites probably control the 
function of stem cell and cancer growth. The group concluded that the effect of ER-
dependent and -independent in cancer development need to be considered in the choice 
of treatment because anti-estrogens only block receptor-mediated pathways while 
aromatase inhibitors can block both receptors- and non-receptor-mediated mechanism 
(Yue et al., 2013). As it is, the percentage of risk from both the gene mutations and 
estrogens effect is then found to be low compared to the exogenous factors. Therefore, 
prevention of breast cancer ought to target mostly the exogenous factors especially 
lifestyle and diet.  
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Diet and lifestyle are indeed important risk factors that can be prevented and 
must be considered in all preventive measures. In this regard, efforts are being made 
by various authorities/organizations, including the Ghana Ministry of Health, to 
promote a good lifestyle and healthy diet. Similarly, research conducted to explore 
new anti-cancer treatments are now focusing on natural compounds from the regular 
human diet since these compounds do not often exhibit severe side-effects due to their 
synergic effect when mixed with the other compositions of the diet; but rather act 
efficiently on a varied range of molecular targets involved in carcinogenesis.  
Prospective studied have revealed that eating patterns characterized by 
increased intakes of fruits, whole grain foods, and vegetables, and lower consumptions 
of processed, red meats and salt, are linked to reduced dangers of cancer, and death. 
Thus, a healthy diet might improve the overall survival rate after the diagnosis of breast 
cancers. Taking all these into account it was ratified that individuals should have a 
healthy diet to lessen the risk of cancer (Fung et al., 2013). They ought to eat a lot of 
whole grains, fruits, legumes, and vegetables; limit foods high in salt and red meat; 
processed meat and avoid sugary drinks; and limit high-calorie foods (Norat et al., 
2015; Schüz et al., 2015). Other case studies also connect a healthy diet to the reduction 
in breast cancer risk predominantly in postmenopausal women (Catsburg et al., 2015) 
and of ER-negative/PR-negative and ER-negative/PR-positive tumours (Dong et al., 
2011). A collective analysis of carotenoid level in the circulating blood further showed 
a lower risk of breast cancer mainly on ER-negative tumours (Eliassen et al., 2012). 
Liu and his/her team correspondingly found an inverse relationship between the intake 
of vegetable protein and fat, dietary fibre, and nuts consumed during adolescence with 




2.5.3. Breast cancer and available treatments 
Treatment for breast cancers is administered according to the type, the stage 
and how far it has been spread. Chemotherapies are often used in the early stage but 
can be added to radiotherapy sections when the stage is advanced. Hormone therapies 
like anti-estrogen therapy and targeted therapies (such as the use of Herceptin, 
Avastin) are also among the medications for breast cancer treatment. Surgical resection 
such as lumpectomy and mastectomy are performed most on late stages of breast 
cancer. People with breast cancer often get more than one kind of treatment.  The 
treatments come either as the main course or as a combination depending on the type 
and stage of cancer and the patient condition. Notwithstanding, the occurrence of drug 
resistance and strong side effects has hampered the efficiency of these treatments. 
Also, the cost of the available treatment makes it difficult for the average people to 
access it. 
2.6. EGFR signaling pathways 
Many specific molecular targets have been investigated to design new 
therapies that will affect tumour growth and survival. Among such is EGFRs which 
are transmembrane receptors.  These receptors are present on the cell membranes and 
have been found to regulate a lot of signal transduction cascades when bound to 
epidermal growth factors (EGF) (Figure 2.1).  
The EGFR family consisted of EGFR1, HER2, EGFR3 and EGFR4 have 
shown different rates of overexpression (EGFR1 in 16.4 %, EGFR3 in 17.5 %, EGFR4 
in 11.9 % and HER2 in 22.8 %,) (Wilson et al., 2009). EGFR1, HER2, and EGFR3 
expression levels were inversely related to that of estrogen receptor (ER) (Witton et 
al., 2003). Upon activation by their specific ligands, EGFRs stimulate intracellular 
signalings, for example, the Ras/Raf/MAPK (Figure 2.2), JAK/STAT, PI3K-AKT and 
24 
 
PLCγ. At the cellular level, EGFR induces cell proliferation, protect against apoptosis 
and alter the cell adhesion and motility; while at the physiological level, it encourages 
invasion and angiogenesis (Masuda et al., 2012).  
  
 
Figure 2. 1 The family of the epidermal growth factor (EGF) (Gupta & Chaphalkar, 
2014) 
 
 
